Member Info for alfista

To say that was written by a so called journo, it is frighteningly uninformed. It could have been written by any one of the amateurs on here. Not you is it?

That was years ago, honestly I hope rampers such as you never get involved, but it's a free board. Revenues are affected by the support given to global brand launches, and that continues, so you will have ammo for a while yet. Matters not. By the way, the Chairman and FD did partake in share buys last year, so that cheap shot was at your foot.

Carry on, I firmly believe that the medium term is in the hands of the investors who have supported recent funding. Semi pro, and brainless, comments on this board will make no difference whatsoever.

Uninformed It already is.

An increasing number of further commercial projects have been initiated by DSM with prospective customers, including some prospective customers which are part of global businesses, with good prospects for these projects to be launched as consumer products. The Company and DSM have seen an encouraging increase in brand awareness and customer interest in Fruitflow® in recent months, and the total projected annual sales value of the prospective sales pipeline for Fruitflow® has continued to increase, now standing at an all-time high level.   MOU for a research and development collaboration with By-Health Co., Ltd for Fruitflow® In April 2017 the Company announced that it had entered into a memorandum of understanding with BY-HEALTH Co., Ltd, a substantial listed Chinese dietary supplement business, which is intended to result in a research and collaboration agreement with BY-HEALTH for Fruitflow®.   The Company also confirmed separately that Provexis and DSM were working with BY-HEALTH to support the planned launch of some Fruitflow® based products in the Chinese market, with the first launch envisaged in the second half of 2017.

Indeed. Had he used Fruitflow Plus Nitrates, might he have avoided the incidence?

Yep, hands up, saw the sp rise and made an assumption. Oh such glee from the long term detractors, let's see who is smiling when they have built the global business.

Very interesting to see DSM=V taking a fair chunk, the same fund that has held Provexis throughout its development. I guess there may be synergies in the supply chain somewhere. They obviously have confidence in the management.

Frequently the actual differs from what you read. Sell at .58, buy at .637 today. No need to be sarcy about such a fact is there.

Real spread is nothing like the posted figure. Limbo until the June PrimaryBid offer is complete. The backing of the investor group, I suspect a China link there, is a sign of good prospects IMHO. As you say Pumpky, they have a good return from their support last year.

Unsurprisingly the petty remarks, whether they be from semi pros, serial moaners or refugees from the WRN board, have come and gone. Since we learned that DSM make a contribution to start up costs for brands launching Fruitflow products, both the scale and growth rates of revenues have become a bit clearer, Growth at all time highs, Fruitflow Plus increasing month on month, another product to add to the Fruitflow Plus range, aimed at sports people, all good IMHO Not much expansion on the next marketing initiatives, after mention of other channels and possible international developments in the previous funding update. I get the feeling that it matters almost not at all what petty squabbles are played out on these boards, the direction of the sp is in the hands of the funding group in the background. Puzzling to see buys at over the PrimaryBid potential price, I thought most serious folks would be keeping their powder dry.

In that case, you may want to review your posting history, because what you've said previously doesn't support today's claim.

Why?

Then you need help with your memory, because it didn't.

"Further UK sales channel opportunities for the product are currently being progressed, and some international sales channel opportunities are being explored." A fall away is more likely? My opinion, as a gnarled old retailer, is that we are still at a very, very early stage of development with the brand, with many more opportunities ahead. The level of support for the funding is beginning to resemble a similar path to others, where greater amounts are raised from investors who see the growth path.

We saw the same strength ahead of confirmation of the placing last year. At that time, I speculated that it was perhaps the placees who wanted a greater stake. Really so little trading of late that I can't see that this time around.

Hopefully the next RNS will lay out the plan for the near term. All time high Fruitflow sales is obviously good, rising sales on Fruitflow +Omega3 is promising. Expanding sales channels is a broad brush term, some more specifics would help. Wouldn't we all like to know who the "small group" are.

Sensible comment over on the other site. Without doubt volume has been held down by the inclusion in the last report of the plan to raise funds. The timescale has now expired, which is good, in that it displays no special urgency, but it also allows the uncertainty to persist, which isn't so good. A buy at over Ask may be the indicator that the chartists see, but on the current volume surely that means very little. I'd hope the funds are raised on PrimaryBid this time. Hoping for an alert from them. On a couple of occasions the offer period has been while the market is closed on other share offers on PB. Whether that makes for less volatility or not is debatable, but we know the type of news that will move things here. More new brands in the huge China health supplement market is the most likely, although new things could appear anywhere globally.

Mission Healthcare continues to grow, a very tasty bolt on acquisition.

The article refers to a single product. The proportion of flavonoids can be deduced from the same article. Not rocket science.